Elevance Health

Stock

Ticker: ELV

ELV

Price

Debate sobre ELV

Puestos

Mater

@Mater

6Lun·

My latest pick-ups!

I been pickin' up stocks left and right, faster than Lightning McQueen on a straightaway!

My latest haul? Oh boy, I got me a whole garage full of winners:

$ASTS (-7,26 %) — that's my wild space-racin' satellite buddy, shootin' for the stars!

$ELV (-0,21 %) — solid as an old tow truck, that healthcare giant's built to last through any storm. $WDAY (-3,05 %) — workin' hard in the cloud, just like me haulin' tractors all day.

$TEAM (-4,55 %) — Atlassian, my new collaboration tractor! Keeps all them teams workin' together smoother than a fresh coat of rust-proof paint.

$MSFT (-1,82 %) — the big blue-chip boss, steady and smart as Doc Hudson.

And $DASH (-1,76 %) — zoomin' around deliverin' food quicker than Flo's diner on a busy night!

Most of 'em are performin' great, and lemme tell ya… these babies are long-term keepers. I'm talkin' hold 'em through the bumps, the potholes, and all the way to the finish line.

No quick flips here — we're in it for the long haul, just like a good ol' friendship!

BamBamInvest

@BamBamInvest

11Lun·

UnitedHealth Group Q3'25 Earning Highlights 🫡

$UNH (-1,66 %)
$XDWH (-0,6 %)

Revenue: $113.2B (Est. $113.156B) ✅; +12% YoY
Adj EPS: $2.92 (Est. $2.84) ✅
Earnings from Operations: $4.3B; -50% YoY

Raises FY25 Guidance:

Adj EPS: at least $16.25 (Est. $16.22) ✅
GAAP EPS: at least $14.90

Q3 UnitedHealthcare (Benefits):

Revenue: $87.1B (Est. $86.72B) ✅; UP +16% YoY
Operating Margin: 2.1%
Consumers Served (U.S.): 50.1M; +795k YoY

Q3 Optum (Health Services)

Revenue: $69.2B (Est. $67.52B) ✅; UP +8% YoY
Optum Health Revenue: $25.9B; flat YoY
Optum Insight Revenue: $4.9B; flat YoY
Optum Rx Revenue: $39.7B; UP +16% YoY
Optum Rx Adjusted Scripts: 414M (407M last year)

Other Metrics:

Operating Cash Flow: $5.9B
Medical Care Ratio (MCR): 89.9% (85.2% a year ago)
Operating Cost Ratio: 13.5% (13.2% a year ago)
Net Margin: 2.1%
Debt-to-Capital Ratio (9/30/25): 44.1%

Comment:

🔸 "We remain focused on strengthening our performance and positioning for sustained and accelerated growth in 2026 and beyond, and our results this quarter reflect the solid execution of this objective."

🔸 Amedisys transaction completed on August 14, 2025; ongoing investments to support future growth.

#earning
#quartalszahlen

$CVS (-0,19 %)
$ELV (-0,21 %)
$US60855R1005 (-2,57 %)
$OSCR (-4,61 %)
$CI (+0,94 %)

Aktien Stammtisch

@Aktien_Stammtisch

11Lun·

Elevance Health Q3 Earnings Beat Expectations

$ELV (-0,21 %)

✅ EPS: $6.03 adj. vs. $4.94 est.

✅ Revenue: $50.1B vs. $49.5B est. (+12% Y/Y)

• Operating margin: 2.6% (↓ from 3.1% Y/Y)

• Reaffirmed FY25 EPS guidance of ~$30 and benefit expense ratio ~90%

• Returned $3.3B to shareholders YTD

📊 Takeaway: Elevance Health delivered a clear earnings beat with strong revenue growth and disciplined execution. Margins remain under pressure, but reaffirmed guidance and solid cash returns highlight operational strength heading into 2026.

BamBamInvest

@BamBamInvest

1Año·

Buffet further increases ?

$UNH (-1,66 %)
$BRK.B (+0,92 %)
$BRK.A (+1 %)

Buffett has probably bought far more than the stated 5 million shares of $UNH (-1,66 %) probably much more.

This can be concluded from the fact that Berkshire Hathaway no longer requires a confidentiality note for the current quarter.

Today's 13F only covers transactions through June 30, we don't know how much he bought after that.

The closing price on this day for $UNH (-1,66 %) was $311.97.

In between there are another 45 days where the price has mostly fallen further.

Therefore, confidential treatment of $BRK.B (+0,92 %) is no longer necessary.

We will find out exactly how much he has collected in 3 months, but I believe that he was not satisfied with the initial purchase with the share price continuing to fall and so much cash on hand 💪

Other buyers:

Tepper
Burry
Simons - Renaissance

$CNC (-2,46 %)
$OSCR (-4,61 %)
$CVS (-0,19 %)
$CI (+0,94 %)
$ELV (-0,21 %)

+ 1

2 Comentarios

RankSquid@RankSquid

1Año

Great breakdown. Where could you find this chart or information?

•

Mostrar respuesta

BamBamInvest

@BamBamInvest

1Año·

United Health

$UNH (-1,66 %)
$CNC (-2,46 %)
$US60855R1005 (-2,57 %)
$ELV (-0,21 %)
$CVS (-0,19 %)

How the loss of $CNC (-2,46 %) and $US60855R1005 (-2,57 %) shows, Medicaid is charity care because you lose money when you care for the sickest and poorest population. To make a profit, you want as few Medicaid patients as possible.

$UNH (-1,66 %) is in a better position ✌️

BamBamInvest

@BamBamInvest

1Año·

Centene Q2'25 result highlights

$CNC (-2,46 %)

Next sale in the health insurance sector ?

🔹 Revenue: USD 48.74 billion (estimated USD 44.24 billion) ✅

🔹 Adjusted earnings per share: ( USD 0.16) (estimated USD 0.23) ❌

🔹 Health insurance ratio: 93.0% (estimated 91.6%) ❌ ; increase of +5.4 percentage points compared to the previous year

🔹 Total income from premiums and services: USD 42.47 billion; increase of 18% compared to the previous year

🔹 Selling and administrative expenses ratio: 7.1 %

Segment revenue:

🔹 Medicaid: USD 21.72 billion; increase of 7% compared to the previous year

Commercial: USD 10.07 billion; increase of 18% compared to the previous year

🔹 Medicare: USD 9.45 billion; increase of 58% compared to the previous year

🔹 Other: USD 1.22 billion; increase of 1% compared to the previous year

Other metrics

🔹 Cash flow from operating activities: USD 1.79 billion

🔹 Payability days for claims: 47 days

CEO comment:

➡️ "We are disappointed with our second quarter results, but have a clear understanding of the trends that impacted our performance and are working diligently and with focus to restore our earnings performance." - Sarah M. London

➡️ "Despite the changing landscape, we believe the staying power of Medicaid, Medicare and the Individual Marketplace is stronger than ever." - Sarah M. London

$UNH (-1,66 %)
$US60855R1005 (-2,57 %)
$CVS (-0,19 %)
$CI (+0,94 %)
$XDWH (-0,6 %)

14 Comentarios

HyperX@AxoWallStreet

1Año

A big fish must have just made a purchase at $CNC

•

Ver todas las 2 respuestas adicionales

BamBamInvest

@BamBamInvest

1Año·

Valuation Healthcare sector - Goldman Sachs

$XDWH (-0,6 %)
$XLV (-0,63 %)
$CSPX (-1,25 %)
$VUSA (-1,24 %)
$UNH (-1,66 %)
$OSCR (-4,61 %)

According to Goldman Sachs, healthcare is the only sector in the S& P 500 that is cheaper than the 10- and 30-year averages.

This is an extremely attractive risk/reward ratio and the coming months will be exciting.

$ELV (-0,21 %)
$CNC (-2,46 %)
$DHR (-1,12 %)
$SRT (-1,92 %)
$LLY (+0,49 %)
$NOVO B (-1,65 %)
$NVO (-1,26 %)
$ISRG (-0,56 %)
$JNJ (+0,73 %)
$ABBV (+0,71 %)
$PFE (+0,31 %)
$SAN (-0,06 %)
$MRK (+0,33 %)
$BMY (-1,22 %)
$TMO (-1,05 %)

BamBamInvest

@BamBamInvest

1Año·

Weak US healthcare sector

$UNH (-1,66 %)
$OSCR (-4,61 %)
$XDWH (-0,6 %)
$ELV (-0,21 %)
$LLY (+0,49 %)
$XLV (-0,63 %)

The US healthcare sector is experiencing its biggest crash in the last 20 years.

If the strong weighting no. 1 $LLY (+0,49 %) (over 12%), one would have to go back even further/longer. (probably before the existence of the ETF).

I have positioned myself strongly here as I believe this is a great opportunity.

I also believe that a lot of capital will flow into the sector in the coming months. ✌️

Do you have a similar view? ✌️

6 Comentarios

Tenbagger-Capital@Tenbagger-Capital

1Año

I still have one US pharma share on my buy list.
But I'm wondering whether I should get in before August.

•

Ver todas las 3 respuestas adicionales

BamBamInvest

@BamBamInvest

1Año·

Weak US healthcare sector

$UNH (-1,66 %)
$OSCR (-4,61 %)
$XDWH (-0,6 %)
$ELV (-0,21 %)
$LLY (+0,49 %)
$XLV (-0,63 %)

The US healthcare sector is experiencing its biggest crash in the last 20 years.

If the strong weighting no. 1 $LLY (+0,49 %) (over 12%), one would have to go back even further/longer. (probably before the existence of the ETF).

I have positioned myself strongly here as I believe this is a great opportunity.

I also believe that a lot of capital will flow into the sector in the coming months. ✌️

Do you have a similar view? ✌️

17 Comentarios

Tenbagger-Capital@Tenbagger-Capital

1Año

I think it will remain exciting for health insurers because I see a problem in keeping margins at the same level.
I see the medical device manufacturer sector as very exciting due to AI and robotics. Companies such as $SYK Stryker and $GMED etc. could be interesting here.
Humanoid care robots can already be seen in some nursing homes.
But the biotech sector is also being shaken up by AI.
Here I continue to bet on $CORT and $VRTX on the buy list is $EXEL

•

Ver todas las 9 respuestas adicionales

BamBamInvest

@BamBamInvest

1Año·

Elevance Health Q2 '25 Earnings Highlights

$ELV (-0,21 %)

EPS: $8.84 vs $9.07 expected ❌
Revenue: $49.4 billion vs $48.14 billion expected ✅
FY25 EPS guidance: $30.00 vs $34.48 consensus ❌

Benefit cost ratio: 88.9%; increase of +260 basis points compared to the previous year
Operating expense ratio: 10.1 %; decrease of -160 basis points compared to the previous year

The second-largest health insurer reported its profits. Although these were below consensus, they were not too bad given the panic in the industry.

The benefit cost ratio was 88.9%, an increase of 260 basis points from the previous year, reflecting the trend toward higher medical costs, particularly in the Medicaid business and ACA health plans.

CEO Comment:

"In the second quarter, Elevance Health made significant progress in delivering a simple and personalized experience for our customers while advancing our efforts to improve efficiencies across the health system ... With the embedded earnings power of our diversified Health Benefits and Carelon businesses, we remain confident in our ability to deliver at least 12% compound annual growth in adjusted diluted earnings per share over time." - Gail K. Boudreaux

$UNH (-1,66 %)
$CNC (-2,46 %)
$US60855R1005 (-2,57 %)
$CVS (-0,19 %)
$OSCR (-4,61 %)

BamBamInvest

@BamBamInvest

1Año·

Further increased

$UNH (-1,66 %)

$UNH (-1,66 %) has not experienced two consecutive years of negative returns since 1987.

Who is still invested here, who is buying, what are your assessments? 🤔

In my opinion, a lot of negative things are already priced in here.

There is no evidence for the accusations
Every accusation is contradicted and more openness is also suggested
They are regularly reviewed and nothing negative has been found
Bad "old" news is constantly being rehashed which has already been dismissed as unfounded and unproven
CEO and other insiders have set an example by buying it
$UNH (-1,66 %) is one of the largest employers in the US and also system relevant
Medicare/Medicaid accounts for only 15% of revenue
Outlook/expectations have already been reduced
Historically high dividend yield of just under 3%
Possible penalties already priced in in my opinion

yes, of course there is still downside potential, but the risk/reward ratio is already very attractive

The entire sector has similar ways of working and a decline/reduction in Medicare could $UNH (-1,66 %) as the top dog in the private sector could even play into its hands.

UnitedHealth Group $UNH (-1,66 %) has traded at the largest deviation from the S&P 500 price-to-earnings ratio since its IPO ...

This stock has literally NEVER been this cheap relative to the S&P 500.

Incredibly exciting to follow the story.

$CNC (-2,46 %)
$CVS (-0,19 %)
$OSCR (-4,61 %)
$HUM (+0,16 %)
$CI (+0,94 %)
$ELV (-0,21 %)
$XDWH (-0,6 %)

15.07

UnitedHealth Group Incorporated

Compró 11 a 251,45 €

2765,95 €

17 Comentarios

Rügen W.@SSIT

1Año

How many shares are you up to now? There should already be a lot of skin in the game. 😁

EDIT: At UNH, of course.

•

Mostrar respuesta

Aktien Stammtisch

@Aktien_Stammtisch

1Año·

Elevance Health Q2 ’25 Earnings Highlights

$ELV (-0,21 %)

🔹 Adj EPS: $8.84 (Est. $9.07) 🔴

🔹 Revenue: $49.4 B (Est. $48.14B) 🟢; +14.3% YoY

FY25 Guidance

🔹Adj EPS: $30.00 (Est. $34.48) 🔴

Q2 Segment / Product Results

🔹 Health Benefits revenue: $41.6 B; UP +12% YoY

🔹 Health Benefits operating margin: 3.8%; DOWN –200 bp YoY

🔹 Carelon revenue: $18.1 B; UP +36% YoY

🔹 Carelon adjusted operating margin: 5.2%; DOWN –40 bp YoY

Other Metrics

🔹 Benefit expense ratio: 88.9%; UP +260 bp YoY

🔹 Operating expense ratio: 10.1%; DOWN –160 bp YoY

🔹 Returned $2.0 B capital to shareholders YTD

CEO Commentary

🔸 “In the second quarter, Elevance Health made meaningful progress in delivering an experience that is simple and personal to those we serve, while advancing our efforts to enhance efficiency across the healthcare system… With the embedded earnings power of our diversified Health Benefits and Carelon businesses, we remain confident in achieving at least 12% average annual growth in adjusted diluted EPS over time.” – Gail K. Boudreaux

BamBamInvest

@BamBamInvest

1Año·

Further increased

$UNH (-1,66 %)

$UNH (-1,66 %) has not experienced two consecutive years of negative returns since 1987.

Who is still invested here, who is buying, what are your assessments? 🤔

In my opinion, a lot of negative things are already priced in here.

There is no evidence for the accusations
Every accusation is contradicted and more openness is also suggested
They are regularly reviewed and nothing negative has been found
Bad "old" news is constantly being rehashed which has already been dismissed as unfounded and unproven
CEO and other insiders have set an example by buying it
$UNH (-1,66 %) is one of the largest employers in the US and also system relevant
Medicare/Medicaid accounts for only 15% of revenue
Outlook/expectations have already been reduced
Historically high dividend yield of just under 3%
Possible penalties already priced in in my opinion

yes, of course there is still downside potential, but the risk/reward ratio is already very attractive

The entire sector has similar ways of working and a decline/reduction in Medicare could $UNH (-1,66 %) as the top dog in the private sector could even play into its hands.

UnitedHealth Group $UNH (-1,66 %) has traded at the largest deviation from the S&P 500 price-to-earnings ratio since its IPO ...

This stock has literally NEVER been this cheap relative to the S&P 500.

Incredibly exciting to follow the story.

$CNC (-2,46 %)
$CVS (-0,19 %)
$OSCR (-4,61 %)
$HUM (+0,16 %)
$CI (+0,94 %)
$ELV (-0,21 %)
$XDWH (-0,6 %)